Kelly P H, Iversen L L
Psychopharmacologia. 1975 Dec 31;45(2):221-4. doi: 10.1007/BF00429064.
The dopamine agonist apomorphine (1.0 mg/kg i.p.) produced an enhanced stimulation of locomotor activity compared to control animals in rats injected bilaterally 14 days previously with 6-hydroxydopamine (6OHDA) into the nucleus accumbens. (+)-Lysergic acid diethylamide (LSD) also produced a marked stimulation of locomotor activity in the 6OHDA treated animals at a dose (1.0 mg/kg i.p.) which was ineffective in control rats. (+)-Bromo-lysergic acid diethylamide (2.0 mg/kg i.p.) did not stimulate locomotor activity in 6OHDA treated rats. The locomotor stimulation produced by LSD was blocked by pretreatment with the dopamine antagonist pimozide (0.5 mg/kg i.p.). It is suggested that LSD acts as an agonist at mesolimbic dopamine receptors.
与14天前双侧伏隔核注射6-羟基多巴胺(6OHDA)的大鼠相比,多巴胺激动剂阿扑吗啡(腹腔注射1.0mg/kg)对其运动活性的刺激增强。(+)-麦角酸二乙酰胺(LSD)在腹腔注射剂量为1.0mg/kg时,对6OHDA处理的动物也产生了明显的运动活性刺激,而该剂量对对照大鼠无效。(+)-溴麦角酸二乙酰胺(腹腔注射2.0mg/kg)对6OHDA处理的大鼠的运动活性没有刺激作用。LSD产生的运动活性刺激可被多巴胺拮抗剂匹莫齐特(腹腔注射0.5mg/kg)预处理所阻断。提示LSD作为中脑边缘多巴胺受体的激动剂发挥作用。